Skip to main content
Top
Published in: Journal of Cancer Survivorship 1/2015

01-03-2015

The state of cancer survivorship programming in Commission on Cancer-accredited hospitals in Georgia

Authors: Logan J. Kirsch, Angela Patterson, Joseph Lipscomb

Published in: Journal of Cancer Survivorship | Issue 1/2015

Login to get access

Abstract

Purpose

In Georgia, there are more than 356,000 cancer survivors. Although many encounter challenges as a result of treatment, there is limited data on the availability of survivorship programming. This paper highlights findings from two surveys assessing survivorship care in Commission on Cancer (CoC)-accredited hospitals in Georgia.

Methods

In 2010, 38 CoC-accredited hospitals were approached to complete a 36-item survey exploring knowledge of national standards and use of survivorship care plans (SCPs), treatment summaries (TSs), and psychosocial assessment tools. In 2012, 37 CoC-accredited hospitals were asked to complete a similar 21-item survey.

Results

Seventy-nine percent (n = 30) of cancer centers completed the 2010 survey. Sixty percent (n = 18) reported having a cancer survivorship program in place or in development. Forty-three percent (n = 13) provided survivors with a SCP and 40 % (n = 12) a TS. Sixty percent (n = 18) reported either never or rarely using a psychosocial assessment tool. Sixty-two percent (n = 23) completed the 2012 survey. Ninety-six percent (n = 22) were aware of the new CoC guideline 3.3. Thirty-nine percent (n = 9) provided a SCP and/or TS. Eighty-seven percent (n = 20) stated they were very confident or somewhat confident their organization could implement a SCP and/or TS by 2015.

Conclusions

The data indicated the importance of collaboration and shared responsibility for survivorship care. Broad implementation of SCPs and TSs can help address the late and long-term effects of treatment.

Implications for Cancer Survivors

Increasing knowledge on survivorship care is imperative as the Georgia oncology community engages oncologists and primary care providers to achieve higher quality of life for all survivors.
Appendix
Available only for authorised users
Literature
2.
go back to reference Siegel R, DeSantis C, Virgo K, et al. Cancer treatment and survivorship statistics, 2012. A Cancer Journal for Clinicians. 2012; 10. Siegel R, DeSantis C, Virgo K, et al. Cancer treatment and survivorship statistics, 2012. A Cancer Journal for Clinicians. 2012; 10.
8.
go back to reference Hewitt M, Greenfield S, Stovall E. From Cancer Patient to Cancer Survivor: Lost in Transition. Institute of Medicine. 2005. Hewitt M, Greenfield S, Stovall E. From Cancer Patient to Cancer Survivor: Lost in Transition. Institute of Medicine. 2005.
9.
go back to reference Stanton AL. What happens now? Psychosocial care for cancer survivors after medical treatment completion. J Clin Oncol. 2012;30:1215–20.CrossRefPubMed Stanton AL. What happens now? Psychosocial care for cancer survivors after medical treatment completion. J Clin Oncol. 2012;30:1215–20.CrossRefPubMed
11.
go back to reference Stricker CT, Jacobs LA, Risendal B, et al. Survivorship care planning after the Institute of Medicine recommendations: how are we faring? J Cancer Survivorship. 2011;5:358–70.CrossRef Stricker CT, Jacobs LA, Risendal B, et al. Survivorship care planning after the Institute of Medicine recommendations: how are we faring? J Cancer Survivorship. 2011;5:358–70.CrossRef
12.
go back to reference Earle CC. Failing to plan is planning to fail: improving the quality of care with survivorship care plans. J Clin Oncol. 2006;24:5112–6.CrossRefPubMed Earle CC. Failing to plan is planning to fail: improving the quality of care with survivorship care plans. J Clin Oncol. 2006;24:5112–6.CrossRefPubMed
13.
go back to reference Rechis R, Beckjord EB, Nutt S. Potential benefits of treatment summaries for survivors’ health and information needs: results from a LiveSTRONG survey. Journal of Oncology Practice. 2013. Rechis R, Beckjord EB, Nutt S. Potential benefits of treatment summaries for survivors’ health and information needs: results from a LiveSTRONG survey. Journal of Oncology Practice. 2013.
14.
go back to reference Hewitt ME, Bamundo A, Day R, Harvey C. Perspectives on post-treatment cancer care: qualitative research with survivors, nurses and physicians. J Clin Oncol. 2007;25:2270–3.CrossRefPubMed Hewitt ME, Bamundo A, Day R, Harvey C. Perspectives on post-treatment cancer care: qualitative research with survivors, nurses and physicians. J Clin Oncol. 2007;25:2270–3.CrossRefPubMed
15.
go back to reference Nekhlyudov L, Aziz NM, Lerro C, Virgo KS. Oncologists’ and primary care physicians’ awareness of late and long-term effects of chemotherapy: implications for care of the growing population of survivors. Journal of Oncology Practice. 2013. Nekhlyudov L, Aziz NM, Lerro C, Virgo KS. Oncologists’ and primary care physicians’ awareness of late and long-term effects of chemotherapy: implications for care of the growing population of survivors. Journal of Oncology Practice. 2013.
17.
go back to reference McCabe MS, Bhatia A, Oeffinger KC, Reaman GH, Tyne C, Wollins DS, and Hudson MM. American Society of Clinical Oncology statement: achieving high quality cancer survivorship care. Journal of Clinical Oncology. 2013. McCabe MS, Bhatia A, Oeffinger KC, Reaman GH, Tyne C, Wollins DS, and Hudson MM. American Society of Clinical Oncology statement: achieving high quality cancer survivorship care. Journal of Clinical Oncology. 2013.
21.
go back to reference Hewitt M, Rowland JH. Mental health service use among adult cancer survivors: analyses of the national health interview survey. J Clin Oncol. 2002;20:4581–90.CrossRefPubMed Hewitt M, Rowland JH. Mental health service use among adult cancer survivors: analyses of the national health interview survey. J Clin Oncol. 2002;20:4581–90.CrossRefPubMed
22.
go back to reference Earle CC, Ganz PA. Cancer survivorship care: don’t let the perfect be the enemy of the good. J Clin Oncol. 2012;30:3764–8.CrossRefPubMed Earle CC, Ganz PA. Cancer survivorship care: don’t let the perfect be the enemy of the good. J Clin Oncol. 2012;30:3764–8.CrossRefPubMed
23.
go back to reference Rosales AR, Byrne D, Burnham C, Watts L, Clifford K, Zuckerman DS, et al. Comprehensive survivorship care with cost and revenue analysis. J Oncol Pract. 2013;10:81–5.CrossRef Rosales AR, Byrne D, Burnham C, Watts L, Clifford K, Zuckerman DS, et al. Comprehensive survivorship care with cost and revenue analysis. J Oncol Pract. 2013;10:81–5.CrossRef
24.
go back to reference Willis A, Pratt-Chapman M, Reed E, and Hatcher E. Best Practices in Patient Navigation and Cancer Survivorship: Moving Toward Quality Patient-Centered Care. Journal of Oncology Navigation & Survivorship. 2014; 5. Willis A, Pratt-Chapman M, Reed E, and Hatcher E. Best Practices in Patient Navigation and Cancer Survivorship: Moving Toward Quality Patient-Centered Care. Journal of Oncology Navigation & Survivorship. 2014; 5.
Metadata
Title
The state of cancer survivorship programming in Commission on Cancer-accredited hospitals in Georgia
Authors
Logan J. Kirsch
Angela Patterson
Joseph Lipscomb
Publication date
01-03-2015
Publisher
Springer US
Published in
Journal of Cancer Survivorship / Issue 1/2015
Print ISSN: 1932-2259
Electronic ISSN: 1932-2267
DOI
https://doi.org/10.1007/s11764-014-0391-1

Other articles of this Issue 1/2015

Journal of Cancer Survivorship 1/2015 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine